|
AN
international group of activists from over 125 counties
urged, in a report released last week, all governments
to strengthen their political will toward the easing
accessibility of drugs to treat HIV-AIDS, a disease that
remains a threat to populations around the world.
The
International Treatment Preparedness Coalition (ITPC)
report included the Philippines as one of those
countries that still have problems of access to
treatment.
Globally, the report said that “at the current pace of
growth in treatment delivery, several million [patients]
will not have access by the end of 2010.”
Highly
developed countries in the Group of Eight (G8) eye 2010
as the target for providing universal access to
treatment and prevention of the acquired
immunodeficiency syndrome (AIDS).
“Estimates of [human immunodeficiency virus] incidence
and prevalence will change, but by any account, several
million people in desperate need of AIDS treatment do
not have access to it,” said the report, “Missing the
Target #5: Improving AIDS Drug Access and Advancing
Health Care for All.”
The ITPC
warned, “Broken promises will mean millions of deaths.”
The report said one of the countries with the problem of
access to treatment is the Philippines. “In the
Philippines, treatment is not yet accessible to all,
there is a health-care worker shortage and diagnostic
testing access is limited.”
The ITPC
conclusion was based on the report of Remedios AIDS
Foundation Inc. personnel Nenet L. Ortega and Noel
Quinto and Pinoy Plus Association Inc. president Eddy
Razon that said the government remained slow in
delivering needed drugs and lacked skilled health
workers.
The
Philippine report said, “As of October 2007, nearly all
of the almost 500 people diagnosed with AIDS in the
Philippines are not receiving antiretroviral treatment
[ART].”
The authors added that even if “there are now 11
treatment centers distributed around the country, the
number of adequately trained and competent health
providers capable of providing HIV/AIDS management
remains limited.”
They
said “Many have chosen not to begin treatment because
they fear potential side effects, a situation that
indicates a lack of appropriate treatment literacy and
education among HIV-positive individuals.”
The
Philippine report authors said the Department of Health
and the Joint United Nations Programme on AIDS
characterized the HIV incidence in the Philippines as
“low and slow” but “hidden and growing.”
“Since
1984, when the first individual was diagnosed, a
cumulative total of 2,916 HIV cases have been officially
registered,” although World Health Organization
estimates that perhaps 10,000 Filipinos may be
HIV-positive but unaware of their serostatus.
Serostatus is the presence or absence of antibodies in a
person’s blood serum. A person can be seropositive if
antibodies are present or seronegative if antibodies are
not present.
According to official data, 2,146 Filipinos are
asymptomatic and 770 have been diagnosed with AIDS, of
whom 304 have died. “The official numbers do not include
those diagnosed outside of the country.”
Ortega
and her coauthors noted that four years ago, the
government promised to provide these Filipinos with
access to comprehensive treatment, care and support,
tapping a global fund for the purchase of drugs.
But, the
authors noted, several factors intervened to hamper the
government’s ability to procure sufficient drugs,
including failure to register with the Philippine
National Drug Formulary the essential antiretroviral
drugs, no estimate for bulk drug purchase because HIV
clinics could not produce the pertinent data.
“Drug
distribution mechanisms were not yet organized;
diagnostic tests were unavailable, including those for
CD4 counts, viral load, and liver function; and standard
treatment guidelines had not yet been established,” said
the authors.
The
authors also noted “Not all treatment centers have
community-based partners that can conduct treatment
follow-up, counseling, and home visits for those on ART.
There is no well-established mechanism to refer clients
to other potentially useful health and social
services.”
The
authors also took a swipe at local governments in
regions with treatment centers that they said “are not
shouldering their responsibilities” for delivery of
drugs. |